GM-CSF
GM-CSF (granulocyte-macrophage colony-stimulating factor, encoded by CSF2 and also written GMCSF) is a secreted cytokine that controls the production, differentiation and function of granulocytes and macrophages. It stimulates the growth of haematopoietic precursor cells from several lineages. Browse Assay Genie's current range of GM-CSF research reagents below, or read on for the biology behind the target.
GM-CSF is a cytokine that stimulates the growth and differentiation of haematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes. Through these actions it controls the production, differentiation and function of granulocytes and macrophages. The active form of the protein is found extracellularly as a homodimer, consistent with its annotation as a secreted factor. It also plays a role in promoting tissue inflammation.
The human CSF2 gene encodes a protein that belongs to the GM-CSF family and sits in the HGNC gene group of colony stimulating factors. The gene is localised to a cluster of related genes at chromosome region 5q31, alongside those encoding interleukins 4, 5 and 13. This region is known to be associated with interstitial deletions in the 5q- syndrome and acute myelogenous leukaemia. The mouse and rat orthologues are both named Csf2, so the gene can be studied in rodent models.
The gene was previously named colony stimulating factor 2 (granulocyte-macrophage), and GMCSF is a recognised alias. Its biology links to inflammation and lung homeostasis: elevated levels of cytokines including GM-CSF have been detected in SARS-CoV-2 infected patients who develop acute respiratory distress syndrome, and mice deficient in this gene or its receptor develop pulmonary alveolar proteinosis. The receptor includes the beta subunit encoded by CSF2RB, which makes receptor and ligand useful to study together.
GM-CSF stimulates growth and differentiation of precursor cells into granulocytes, macrophages, eosinophils and erythrocytes, making it central to studies of myeloid development.
The gene plays a role in promoting tissue inflammation, so GM-CSF is a frequent focus when dissecting inflammatory cytokine signalling.
Elevated cytokines including GM-CSF are seen in SARS-CoV-2 patients with acute respiratory distress syndrome, and deficient mice develop pulmonary alveolar proteinosis.
CSF2 lies in the 5q31 cluster with IL4, IL5 and IL13, a region associated with 5q- syndrome and acute myelogenous leukaemia.
GM-CSF is a secreted cytokine that stimulates the growth and differentiation of haematopoietic precursor cells, including those giving rise to granulocytes, macrophages, eosinophils and erythrocytes. It controls the production, differentiation and function of granulocytes and macrophages, and promotes tissue inflammation.
The official gene symbol is CSF2, for colony stimulating factor 2. GM-CSF and GMCSF are aliases, and the previous gene name was colony stimulating factor 2 (granulocyte-macrophage). UniProt lists the protein as granulocyte-macrophage colony-stimulating factor, a member of the GM-CSF family.
Yes, both mouse and rat have a Csf2 orthologue. Mice deficient in the gene or its receptor develop pulmonary alveolar proteinosis. The human gene lies at 5q31, a region associated with 5q- syndrome and acute myelogenous leukaemia. Check the datasheet of any product for its validated reactivity.
Receptor subunits and related cytokine-signalling targets that sit alongside GM-CSF in haematopoietic research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04141; product specifications from Assay Genie datasheets.